PleoPharma, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to PP-01, the company’s lead investigational asset aimed at mitigating Cannabis ...

Received overwhelming shareholder support in favour of take-private transaction with AditxtAdvanced key pipeline programs, engaged regulatory ...

Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

Changes are coming to Medicare costs and coverage in 2024. Announced in time for the annual open enrollment period, which ...

A Medicare Supplement—or Medigap—plan is an insurance plan that helps pay for gaps in coverage from Original Medicare. Anthem ...

Scott Gottlieb supports a reversion to an earlier interpretation of the 21st Century Cures Act, which would exempt more types ...

A plan for the US Food and Drug Administration to propose banning formaldehyde and certain formaldehyde-releasing chemicals ...

President Donald Trump said he is serious about wanting Canada to become the 51st state in an interview that aired Sunday ...

The taxing plan, tucked into Mills' two-year $118 billion preliminary ... Dowling said the new tax would only apply to ...

The biggest risk is not that Mr. Trump is committed to a gloves-off plan for the cartels. It’s that, beyond the tough talk, ...

Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...